Biogen (BIIB) Gross Profit (2009 - 2026)

Biogen's Gross Profit history runs 18 years deep, the most recent figure standing at $1.8 billion for Q1 2026.

• In Q1 2026, Gross Profit rose 0.84% year-over-year to $1.8 billion; the TTM figure through Mar 2026 stood at $7.5 billion (up 1.11% YoY), while the FY2025 annual figure was $7.5 billion, up 1.64% from the prior year.
• Gross Profit was $1.8 billion for Q1 2026 at Biogen, up from $1.8 billion in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $2.4 billion in Q4 2022 to a low of $1.7 billion in Q1 2024.
• Historically, Gross Profit has averaged $2.0 billion across 5 years, with a median of $1.9 billion in 2023.
• The sharpest annual moves came in 2023 and 2025: Gross Profit decreased 20.23% in 2023, then grew 6.34% in 2025.
• A 5-year view of Gross Profit shows it stood at $2.4 billion in 2022, then declined by 6.63% to $2.2 billion in 2023, then declined by 15.8% to $1.9 billion in 2024, then dropped by 4.67% to $1.8 billion in 2025, then grew by 1.84% to $1.8 billion in 2026.
• The last three Gross Profit figures came in at $1.8 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.9 billion (Q3 2025), per Business Quant data.